microRNA exchange via extracellular vesicles in cancer

Cell Proliferation - Tập 53 Số 11 - 2020
Luyen Tien Vu1,2, Jinhua Gong3,1, Thach Tuan Pham1,2, Yeokyeong Kim1, Minh T. N. Le3,1,2
1Department of Biomedical Sciences, College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong
2Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
3City University of Hong Kong Shenzhen Research Institute, Shenzhen, China

Tóm tắt

AbstractCells utilize different means of inter‐cellular communication to function properly. Here, we review the crosstalk between cancer cells and their surrounding environment through microRNA (miRNA)‐containing extracellular vesicles (EVs). The current findings suggest that the export of miRNAs and uptake of miRNA‐containing EVs might be an active process. As post‐transcriptional regulators of gene expression, cancer‐derived miRNAs that are taken up by normal cells can change the translational profile of the recipient cell towards a transformed proteome. Stromal cells can also deliver miRNAs via EVs to cancer cells to support tumour growth and cancer progression. Therefore, gaining a better understanding of EV‐mediated inter‐cellular communication in the tumour microenvironment might lead to the development of novel diagnostic and therapeutic strategies.

Từ khóa


Tài liệu tham khảo

10.1016/j.ceb.2018.06.001

Lawson C, 2017, Extracellular vesicles: evolutionarily conserved mediators of intercellular communication, Yale J Biol Med, 90, 481

10.1038/ncb1596

10.1038/nrm.2017.125

10.1093/femsre/fuy042

10.1016/S0092-8674(04)00045-5

10.1101/gr.082701.108

10.1261/rna.2183803

10.2174/2211536607666180416152112

10.1371/journal.pone.0201069

Wang X, 2017, Methods and Protocols, 351

10.2174/2211536607666180206150503

10.1186/s12885-019-6037-y

10.1167/iovs.19-27062

10.2217/bmm.13.44

10.1016/j.fsigen.2017.12.010

10.2174/22115374OTczaODEDTcVY

10.4143/crt.2014.46.2.178

10.1111/resp.13364

Virgilio E, 2018, Gastric juice microRNAs as potential biomarkers for screening gastric cancer: a systematic review, Anticancer Res, 38, 613

10.1016/j.fertnstert.2017.11.036

10.1371/journal.pone.0208580

Ardekani AM, 2010, The role of microRNAs in human diseases, Avicenna J Med Biotechnol, 2, 161

10.3389/fgene.2019.00626

10.4172/2155-9929.1000251

10.3390/cells8070737

10.1038/mtna.2014.29

10.1002/brb3.941

10.1021/acs.est.8b06457

10.1371/journal.pone.0037395

10.1161/ATVBAHA.112.300741

10.1073/pnas.1019055108

10.1080/20013078.2018.1481321

10.1016/j.als.2016.11.007

10.1074/jbc.M112.446831

10.1038/ncomms3980

10.1016/j.celrep.2016.09.031

10.7554/eLife.07197

10.7554/eLife.19276

10.7554/eLife.47544

10.1534/g3.116.036137

10.1016/j.celrep.2014.07.035

10.3402/jev.v3.23784

10.1080/21541248.2016.1215283

10.1038/s41598-018-28481-z

10.1016/j.cell.2019.02.029

10.1016/j.febslet.2015.11.036

10.1002/2211-5463.12173

10.1038/s41388-019-1087-9

10.3402/jev.v3.24641

10.1038/s12276-019-0223-5

10.1016/j.biocel.2012.06.018

10.1038/nature15756

10.1182/blood-2008-08-174094

10.1182/blood-2009-07-231449

10.1111/j.1365-2567.2006.02483.x

10.1371/journal.pbio.1001448

10.1182/blood-2011-02-338004

10.1182/blood-2013-03-489732

10.1074/jbc.M109.041152

10.1146/annurev.biochem.68.1.863

10.1083/jcb.201506084

10.1186/s12929-018-0494-5

10.1371/journal.pone.0055214

10.3390/ijms19020591

10.1016/j.ccell.2014.09.005

10.1172/JCI75695

10.3109/03009734.2012.654859

10.1080/20013078.2019.1599680

10.1111/cas.12747

10.1038/ncb3399

10.1002/mc.22935

10.1016/j.cell.2011.02.013

10.1038/s41467-018-03224-w

10.3892/or.2017.5697

10.18632/oncotarget.9246

10.1073/pnas.1209414109

10.1158/0008-5472.CAN-16-2984

10.1016/j.it.2016.09.006

10.1016/j.cellimm.2014.09.004

10.18632/oncotarget.4924

10.1016/j.imbio.2015.07.012

10.1080/2162402X.2015.1062968

10.1038/cr.2014.121

10.1038/emboj.2012.183

10.1016/j.molcel.2010.06.010

10.1074/jbc.M113.489302

10.1074/jbc.M113.480822

10.18632/oncotarget.14247

10.1016/j.omtn.2018.02.014

10.1038/onc.2014.300

10.1016/j.bbagrm.2014.09.002

10.1007/s10456-015-9474-5

10.1016/j.omtn.2020.03.002

10.1038/onc.2017.105

10.1182/blood-2014-05-576116

10.1002/jcp.26202

10.1016/j.canlet.2015.10.011

10.1016/j.ccr.2014.03.007

10.1038/ncb3094

10.1093/carcin/bgy115

10.18632/oncotarget.20009

10.1038/s41467-018-07810-w

10.1038/ncomms11150

10.1093/jnci/djv135

10.1186/1476-4598-10-117

10.1186/s13046-017-0528-y

10.1158/0008-5472.CAN-18-0124

10.18632/oncotarget.14752

10.1186/s13046-019-1027-0

10.1038/nature15376

10.1080/20013078.2019.1648167